Offer - Urjas Oil for just ₹ 1 X
Olmax M 20 Mg/50 Mg Tablet is a prescription drug, available for use as Tablet. Olmax M 20 Mg/50 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Olmax M 20 Mg/50 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The side effects typically associated with Olmax M 20 Mg/50 Mg Tablet include Upper respiratory tract infection, Slow heart rate (pulse). While these are the most often observed Olmax M 20 Mg/50 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Olmax M 20 Mg/50 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Olmax M 20 Mg/50 Mg Tablet is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Olmax M 20 Mg/50 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmax M 20 Mg/50 Mg Tablet related warnings section.
Olmax M 20 Mg/50 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) are examples of such conditions. Some other conditions that can be affected by Olmax M 20 Mg/50 Mg Tablet are listed in the contraindications section below.
Drug reaction of Olmax M 20 Mg/50 Mg Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Olmax M 20 Mg/50 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmax M 20 Mg/50 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmax M 20 Mg/50 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Olmax M. If you are pregnant, do not take Olmax M without a doctor's advice.
Is the use of Olmax M 20 Mg/50 Mg Tablet safe during breastfeeding?
Olmax M may have very limited harmful effects for breastfeeding women.
What is the effect of Olmax M 20 Mg/50 Mg Tablet on the Kidneys?
Olmax M is not harmful for kidneys.
What is the effect of Olmax M 20 Mg/50 Mg Tablet on the Liver?
Olmax M has very mild side effects on the liver.
What is the effect of Olmax M 20 Mg/50 Mg Tablet on the Heart?
Very few cases of side effects of Olmax M on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Olmax M 20 Mg/50 Mg Tablet unless your doctor advises you to do so -
Is this Olmax M 20 Mg/50 Mg Tablet habit forming or addictive?
Olmax M 20 Mg/50 Mg Tablet does not cause addiction.
Interaction between Food and Olmax M 20 Mg/50 Mg Tablet
Taking Olmax M 20 Mg/50 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmax M 20 Mg/50 Mg Tablet
Taking alcohol with Olmax M 20 Mg/50 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850